GI Oncology
Conference Coverage
Study finds no link between platelet count, surgery bleed risk in cirrhosis
Logistic regression analysis showed no significant association between platelet count and major bleeding events.
From the Journals
CRC: Mailing fecal test kits appears cost effective, boosts screening
Individuals who received a reminder and a fecal immunochemical testing kit had an estimated 23.3% colorectal cancer screening rate, compared with...
Guidelines
AGA releases BRCA risk guidance
BRCA carrier status alone should not influence screening recommendations for colorectal cancer or pancreatic ductal adenocarcinoma.
News from the FDA/CDC
Pembro approved for first-line use in MSI-H/dMMR colorectal cancer
This is the first time an immunotherapy has been approved in this setting and as monotherapy.
Conference Coverage
Lipid-lowering drugs appear to decrease risk of colorectal cancer death across subgroups
The risk of death was reduced regardless of age, sex, race, or duration of lipid-lowering drug use.
Conference Coverage
Minority-serving hospitals had similar survival after liver cancer surgery
Overall survival was not linked to whether patients were treated at minority-serving hospitals.
From the Journals
EBV may worsen immune checkpoint inhibitor–induced colitis
All EBV-positive patients had colon perforation, compared with no EBV-negative patients.
From the Journals
GI cancer death disproportional to incidence rates
An analysis of global cancer databases found that deaths from gastrointestinal cancers in 2018 were disproportionately higher than incidence rates...
From the Journals
AGA clinical practice update: Pancreatic cancer screening
Screening should be considered in patients with high risk of pancreatic cancer based on family history and other medical and genetic factors.
From the Journals
American Cancer Society update: ‘It is best not to drink alcohol’
From the Journals
Vaccination regimen effective in preventing pneumonia in MM patients